Table 2 Treatments
| Â | Clozapine N = 6 | Risperidone N = 20 | Olanzapine N = 31 | Quetiapine N = 19 |
|---|---|---|---|---|
SGA Medication | ||||
Dose (mg) | 441.3 ± 142.9 | 2.7 ± 1.6 | 10.4 ± 5.8 | 330.3 ± 300.9 |
Duration (months) | 12.7 ± 12.4 | 12.8 ± 10.7 | 9.8 ± 11.5 | 7.4 ± 3.9 |
Other treatments with metabolic side effects 1 | 3 (50%) | 3 (16%) | 7 (23%) | 5 (26%) |
Previous treatment | ||||
Naive* | 0 | 10 (50%) | 13 (42%) | 2 (10%) |
SGA** | 3 (3%) | 3(15%) | 6(19%) | 11 (58%) |
FGA | 3 (11%) | 7 (35%) | 12 (39%) | 6 (32%) |